任职要求:
最低一篇中科院2区的第一作者文章
导师简介:
姓名:王俊
任职:上海市第一人民医院(上海交通大学医学院附属第一人民医院)
临床研究院疑难疾病精准研究中心课题组长
电子邮箱:junwang2023@sjtu.edu.cn
个人简介(300字以内):王俊,研究员,博士生导师,国家青拔(2022),广东省杰青(2021)。长期从事黏膜损伤相关慢病的免疫机制和靶向治疗研究,取得了创新性的研究成果:1.首次发现新生儿肝内自身反应性B细胞前体异常活化参与胆道闭锁的自身免疫肝损伤,通过美罗华清除自身反应性B细胞可缓解胆道闭锁的肝损伤(2020,Cell);2.发现介导哮喘和社区获得性肺炎发生发展的呼吸道黏膜免疫新机制(2025,ScienceAdvance;2025,2020MucosalImmunology)。主持包括国家高层次人才青年项目、国自然、广东省自然科学杰出青年等项目。
主持科研项目(省部级和国家级):
1.25ZR1401302上海市科委自然科学基金面上项目2025-07~2028-0620万元课题负责人,在研
2.NRCTM(SH)-2025-052025年度国家转化医学中心(上海)开放课题项目2025-01~2026-1228万元课题负责人,在研
3.国家高层次人才特殊支持计划青年拔尖人才项目2023-01~2025-12190万元课题负责人,在研
4.2022B1515020109广东省自然科学基金杰出青年项目2022-01~2025-12100万元课题负责人,在研
5.32070918国家自然科学基金面上项目2021-01~2024-1258万元课题负责人,结题
6.上海市第一人民医院科研启动经费2023-08~2027-07,300万元,课题负责人,在研
代表性论著(10篇以内)
1.GaoyuLiu#,YingWang#,XianfuYi#,JianyeWang,JunZhang,XixiFeng,HaitaoWang,ChunChen,QiangLiu*,JunWang*,JieZhou*.BACH2drivesthedevelopmentandfunctionofgroup2innatelymphoidcells.ScienceAdvances.(Inpress,2025/08/01online)
2.MaoxiaoFeng#,ChengweiChai#,*,XiaodongHao#,XiaojiangLai#,YuanyuanLuo,HongZhang,WenzhuTang,NingxinGao,GuihongPan,XiaojieLiu,YunshanWang,WenjingXiong*,QiangWu*,JunWang*.InheritedKDM6AA649Tfacilitatestumor-immuneescapeandexacerbatescolorectalsignet-ringcellcarcinomaoutcomes.Oncogene.2024Jun;43(23):1757-1768.doi:10.1038/s41388-024-03029-w.
3.BingtaiLu#,YanfangZhang#,JunWang#,DiyuanYang#,MingLiu,LiuheyiMa,WeijingYi,YufengLiang,YingyiXu,HuifengFan,WeiLiu,JueTang,SengqiangZeng,LiCai,LiZhang,JunliNie,FenZhang,XiaoqiongGu,JaimeSRosaDuque*,GenLu*,YuxiaZhang*.PD1+CD4+TcellspromotereceptoreditingandsuppressautoreactivityofCD19+CD21lowBcellswithinthelowerrespiratoryairwaysinadenoviruspneumonia.MucosalImmunol.2024Oct;17(5):1045-1059.doi:10.1016/j.mucimm.2024.07.005.
4.MengYao#,YingjiaoCao#,JuanHe#,RuiDong,GaoyuLiu,YingyingChen,JunWang*,JieZhou*.Single-celltranscriptomicanalysisrevealsheterogeneousfeaturesofmyeloid-derivedsuppressorcellsinnewborns.Front.Immunol.15:1367230.doi:10.3389/fimmu.2024.1367230
5.HuahuaXu#,GuihongPan#,JunWang*.Repairingmechanismsfordistalairwayinjuriesandrelatedtargetedtherapeuticsforchroniclungdiseases.CellTransplantation.202332:1-16.
6.JunWang#,YanhuiXu#,ZhanghuaChen#,JiankunLiang#,ZefengLin#,HuiyingLiang#,YipingXu,QiWu,XuanjieGuo,JunliNie,BingtaiLu,BingHuang,HuifangXian,XiaohuiWang,QiangWu,JixiaoZeng,ChengweiChai,MeixueZhang,YuzhenLin,LiZhang,ShanmeiziZhao,YanluTong,XiaoqiongGu,LiangZeng,Zhuang-guiChen,ShuhongYi,TongZhang,DavidDelfouneso,YanZhang,StephenLNutt,AndrewMLew,LiweiLu,FanBai*,HuiminXia*,ZheWen*andYuxiaZhang*.Liverimmuneprofilingrevealspathogenesisandtherapeuticsforbiliaryatresia.Cell,2020,Dec23;183(7):1867-1883.e26.
7.BingtaiLu#,MingLiu#,JunWang#,HuifengFan#,DiyuanYang,LiZhang,XiaoqiongGu,JunliNie,ZhenjunChen,AlexandraJ.Corbett,MichaelJ.Zhan,ShengboZhang,VanessaL.Bryant,AndrewM.Lew,JamesMcCluskey,Hai-binLuo,JunCui,YuxiaZhang*,YifanZhan*,GenLu*.IL-17productionbytissue-residentMAITcellsislocallyinducedinchildrenwithpneumonia.MucosalImmunol.,2020Feb28.doi:10.1038/s41385-020-0273-y.
8.BingHuang#,ZhanghuaChen#,LanlanGeng#,JunWang#,HuiyingLiang#,YujiaCao,HuanChen,WanmingHuang,MeilingSu,HanqingWang,YanhuiXu,YukunLiu,LuB,HuifangXian,HuiwenLi,HuilinLi,LuRen,JingXie,LipingYe,HongliWang,JunhongZhao,PeiyuChen,LiZhang,ShanmeiziZhaoS,TingZhang,BanglaoXu,DiChe,WenyueSi,XiaoqiongGu,LiangZeng,YongWang,DingyouLi,YifanZhan,DavidDelfouneso,AndrewM.Lew,JunCui,WaiHo.Tang,YanZhang,SitangGong*,FanBai*,MinYang*,YuxiaZhang*.Mucosalprofilingofpediatric-onsetcolitisandIBDrevealscommonpathogenicsandtherapeuticpathways.Cell,2019;179(5):1160-1176.e24.doi:10.1016/j.cell.2019.10.027.
9.JunWang#,QingYe#,YananCao#,YubinGuo,XiupingHuang,WentinMi,SideLiu,ChiWang,Hsin-ShengYang,BinhuaP.Zhou,B.MarkEvers,Qing-BaiShe*.SnaildeterminesthetherapeuticresponsetomTORkinaseinhibitorsbytranscriptionalrepressionof4E-BP1,NatureCommunications,2017;8(1):2207.
主要荣誉(5个以内):2019年度中国医学重大进展
薪酬范围:面议